Alkemi

Congratulations to our CEO, Betsy J. Lahue, on being named Most Innovative Rare Disease Value Communication Solutions CEO 2024! She was nominated by our clients because of her commitment to driving their commercial success with evidence-based product value stories. "I'm pleased to accept this honor on behalf of the Alkemi team. Our work with disease advocates, thought leaders, payers, and guideline groups enables effective value demonstration resulting in greater access for patients," said Betsy Lahue. Betsy leads a team of experts in transformative commercial and marketing initiatives, global pricing strategies, early asset development, and product value negotiations with payers and health authorities. Her industry-leading approaches blend real-world data, modeling, and engagement strategies to quantify robust value propositions to payers. Acquisition International Magazine https://lnkd.in/e-eQqy-C #Leadership #Innovation #RareDisease #ValueCommunication #marketaccess #heor

What is the Joint Clinical Assessment (JCA) and how does it impact your business? Join us for a fast facts session at 12:15 TUESDAY JULY 2 to learn about the JCA and its influence on the pharmaceutical market. Lunch Break Policy Fast Facts (15 Minute Session) Turning Challenges into Opportunities: Pharma in the Era of the Joint Clinical Assessment (JCA) Date and Time: 12:15 – 12:30 PM, Tuesday, July 2nd Location: https://lnkd.in/eukFqUus If you are running late please feel free to join the call at any point. Only Alkemi can see participant names to protect attendee privacy. #raredisease #evidence #marketaccess #marketshaping #consulting

Alkemi continues to grow! We are pleased to welcome Lake Murphy to the team! 🎉 Lake has worked exclusively in market access and commercial strategy, partnering with innovative life science organizations to design go-to-market approach, communicate product value, and achieve appropriate access. He has developed pricing strategies for multiple billion-dollar assets and driven client commercial success in US & ex-US markets across a variety of rare disease states. #raredisease #MarketAccess #CommercialStrategy #LifeSciences #Alkemi

Learn about US Policy. Join us for a 15-minute fast facts session to discuss the Pre-Approval Information Exchange Act and how to communicate Pre-Approval Information with payers. Date and Time: 12:15 – 12:30 pm, Wednesday, June 5th Location: https://lnkd.in/eGuGGGkn (Teams Meeting, Only Alkemi can see participant names to protect attendee privacy)

🌟 Alkemi is pleased to share our standout posters from #ISPORAnnual! 🌟 Our team presented timely research and captivating graphics that sparked interesting discussions and demonstrated Alkemi's creativity and attention to detail. Get in touch with us! We warmly welcome the opportunity to share Alkemi's innovative thinking and commitment to excellence with you. #ISPORAnnual #PosterPresentation #HealthcareInnovation #TeamExcellence #raredisease #medtech #marketaccess Kristen Cribbs Wesley B. Lucas Blackmore, MPH Betsy Lahue Robert Lahue

#ISPORAnnual was a warm setting to explore hot topics in #AI, #DigitalHealth #marketaccess. Grateful to work with trailblazers and collaborative visionaries Arthi Chandran, Lana Feng, Ph.D., and John Hernandez 🌟

The Alkemi ISPOR team having fun at #ISPORAnnual. Catching up with old friends and making new ones! Good Times! Wesley B. Betsy Lahue Lucas Blackmore, MPH Kristen Cribbs Robert Lahue #marketshaping #marketaccess #HEOR #Raredisease #medtech

Excited to announce Betsy Lahue's addition to the Corporate Board Member Network! As CEO of Alkemi and Board Member of EvoEndo, her expertise in strategic market shaping aligns perfectly with the Network's commitment to continuous growth. With over 25 years of experience, Betsy specializes in enabling commercial leadership to drive insights and allocate resources for dynamic, value-driven markets, particularly in rare diseases and innovative technologies. Congratulations, Betsy! #commercialsuccess #marketaccess #marketshaping #HEOR #governance #boardmembers #boardgovernance #boardleadership #boardofdirectors

Heading to Atlanta this week? Request an invitation for an exclusive roundtable breakfast with industry leaders from Abbott, Alkemi, Google, and Huma.AI. "AI: Risky Business or a No Brainer?" MARKET ACCESS AI IMPLICATIONS BREAKFAST ROUNDTABLE How AI is Revolutionizing Research Efficiencies & Challenging the Status Quo. Consider what's next and explore the potential of AI to improve individual and organizational performance. Date & Time: 7:00 AM - 8:15 AM, Tuesday May 7th Location: Ruth's Chris Steakhouse Embassy Suites Atlanta Centennial Olympic Park Buffet Breakfast ***Invitation Only*** https://lnkd.in/dxj5QWTU Arthi Chandran Betsy Lahue John Hernandez Lana Feng, Ph.D. #HEOR #marketaccess #ai

Join me #ISPOR2024 on Monday, May 6th from 5-6pm for an engaging discussion with John Hernandez and Arthi Chandran on navigating the digital health landscape! Building A, Level 3, A305 The objectives of this workshop are to introduce the digital health landscape, share real-world case studies, discuss challenges in value and access for digital innovations, and evaluate emerging assessment frameworks across US, UK and EU-4. #DigitalHealth #ValueFrameworks #PaymentPathways #Workshop #RWE #Marketaccess Alkemi Abbott Google Lana Feng, Ph.D.